HealthDay News — The benefits of metformin outweigh the risks for young people with bipolar spectrum disorder who have overweight or obesity and are treated with second-generation antipsychotics, ...
The FDA has approved an expanded indication for risperidone (Uzedy, Teva) extended-release injectable suspension, allowing it to be used for the maintenance treatment of bipolar I disorder in adults, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback